"Tempus has an unwavering commitment to providing ... Clinicians can enhance molecular insights by adding xR RNA sequencing, xF/xF+ liquid biopsy, immunohistochemistry tests such as HER2 and ...

The latest filings show Representative Nancy Pelosi (D-CA), the most active large investor in the U.S. Congress, betting big on AI. Her latest trades include significant new positions in Google parent ...

“Tempus has an unwavering commitment to providing high quality ... Clinicians can enhance molecular insights by adding xR RNA sequencing, xF/xF+ liquid biopsy, immunohistochemistry tests such as HER2 ...

CHICAGO, February 03, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...

Tempus AI, Inc (NASDAQ:TEM) is soaring as investors get behind former House Speaker Nancy Pelosi's latest stock purchase. Yet, as we go through and discuss the setup here, I contend that investors ...

Tempus AI, Inc. is projected to achieve 30% YoY top line growth in Q4 2024 as presented in management's preliminary results. Growth is forecast to continue in the 23-25% range in eFY25. Tempus is ...

Former House Speaker Nancy Pelosi discloses the purchase of 50 call options in Tempus AI with a strike price of $20. Tempus AI on Tuesday announced the national launch of its AI-enabled personal ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as ...

Tempus Ai got a big valuation boost following a disclosure that Nancy Pelosi had purchased call options for the stock. The healthcare AI company also unveiled its new software service today. In a ...

In a report released today, Ryan MacDonald from Needham reiterated a Buy rating on Tempus AI, Inc. Class A (TEM – Research Report), with a price target of $56.00. Discover outperforming stocks ...